EXAS April options mis-priced

The off-label (for lack of a better term) use in Crohn's and IBS would be a huge potential market. I >doubled my action this morning on the dip. Avg on the long is now 10.60.

 

Yup.
That right there is 1.4 million potential annual tests.

http://www.ncbi.nlm.nih.gov/pubmed?cmd=PureSearch&term=(ahlquist da[Author] AND mayo[All Fields])

 

I'm long the may buy rite.

I don't think 8percent short interest is meaningful.

 

Only if they're right!

 

i don't have a dog in this fight so i'll just leave it at this...it only needs to happen once to cause a big loss.

 

So why do you feel the need to "comment" on a Company and technology that you know nothing about?

 

everyone knows there are no sure things..

 

i was NOT commenting on a company or technology.
i agree i don't know anything about the company or the technology.
i was just trying to help others traders realize that not everything drug will approval at each step and that they should hedge/position size accordingly.

so unless you went to harvard medical school you can't comment on a trade? this is elite trader not elite doctor.

 

i'm done positioning my trade:

33% long may 12 buywrite (cost basis 9.5)
66% long common with may 9 - 12 collar (cost basis 11)

 

Can you explain how you landed on this combination? What would the advantage be over, say, 3 collars?